Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome

Arthritis Research and Therapy

Volumn 15, Issue 4, 2013, Pages

  Lester, Susan ^a   Stokes, Leanne ^b,c   Skarratt, Kristen K ^b   Gu, Ben J ^b,d   Sivils, Kathy L ^e   Lessard, Christopher J ^e   Wiley, James S ^b,d   Rischmueller, Maureen ^a,f  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c RMIT UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^f UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ETHIDIUM; HLA DR3 ANTIGEN; INTERLEUKIN 18; LA ANTIBODY; PURINERGIC P2X7 RECEPTOR; RO ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; RIBONUCLEOPROTEIN; SS-A ANTIBODIES; SS-A ANTIGEN; SS-B ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISTASIS; FEMALE; GAIN OF FUNCTION MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; BLOOD; GENETICS; IMMUNOLOGY;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPISTASIS, GENETIC; FEMALE; GENOTYPE; HLA-DR3 ANTIGEN; HUMANS; INTERLEUKIN-18; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PURINERGIC P2X7; RIBONUCLEOPROTEINS; SJOGREN'S SYNDROME;

EID: 84886792682     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4248     Document Type: Article

References (54)

1. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558. 10.1136/ard.61.6.554, 1754137, 12006334.
2. Nordmark G, Alm GV, Ronnblom L. Mechanisms of Disease: primary Sjogren's syndrome and the type I interferon system. Nat Clin Pract Rheumatol 2006, 2:262-269. 10.1038/ncprheum0173, 16932699.
3. Rischmueller M, Lester S, Chen Z, Champion G, Van Den Berg R, Beer R, Coates T, McCluskey J, Gordon T. HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome (pSS). Clin Exp Immunol 1998, 111:365-371. 10.1046/j.1365-2249.1998.00504.x, 1904917, 9486405.
4. Lester S, McLure C, Williamson J, Bardy P, Rischmueller M, Dawkins RL. Epistasis between the MHC and the RCA alpha block in primary Sjogren syndrome. Ann Rheum Dis 2008, 67:849-854. 10.1136/ard.2007.075044, 2565577, 17878210.
5. Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, Anaya JM. HLA and Sjogren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev 2012, 11:281-287. 10.1016/j.autrev.2011.10.002, 22001416.
6. Elliott JI, McVey JH, Higgins CF. The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products. Arthritis Res Ther 2005, 7:R468-475. 10.1186/ar1699, 1174943, 15899033.
7. Chen L, Brosnan CF. Regulation of immune response by P2X7 receptor. Crit Rev Immunol 2006, 26:499-513. 10.1615/CritRevImmunol.v26.i6.30, 17341191.
8. Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, Payette MM, Brissette W, Wicks JR, Audoly L, Gabel CA. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 2002, 168:6436-6445.
9. Kawamura H, Aswad F, Minagawa M, Govindarajan S, Dennert G. P2X7 receptors regulate NKT cells in autoimmune hepatitis. J Immunol 2006, 176:2152-2160.
10. Gu BJ, Rathsam C, Stokes L, McGeachie AB, Wiley JS. Extracellular ATP dissociates nonmuscle myosin from P2X(7) complex: this dissociation regulates P2X(7) pore formation. Am J Physiol Cell Physiol 2009, 297:C430-439. 10.1152/ajpcell.00079.2009, 19494237.
11. Kim M, Jiang LH, Wilson HL, North RA, Surprenant A. Proteomic and functional evidence for a P2X7 receptor signalling complex. Embo J 2001, 20:6347-6358. 10.1093/emboj/20.22.6347, 125721, 11707406.
12. Pfeiffer ZA, Aga M, Prabhu U, Watters JJ, Hall DJ, Bertics PJ. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J Leukoc Biol 2004, 75:1173-1182. 10.1189/jlb.1203648, 15075366.
13. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006, 442:527-532. 10.1038/nature04886, 16885977.
14. Taylor SR, Gonzalez-Begne M, Dewhurst S, Chimini G, Higgins CF, Melvin JE, Elliott JI. Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J Immunol 2008, 180:300-308.
15. Gourine AV, Wood JD, Burnstock G. Purinergic signalling in autonomic control. Trends Neurosci 2009, 32:241-248. 10.1016/j.tins.2009.03.002, 19359051.
16. Lister MF, Sharkey J, Sawatzky DA, Hodgkiss JP, Davidson DJ, Rossi AG, Finlayson K. The role of the purinergic P2X7 receptor in inflammation. J Inflamm (Lond) 2007, 4:5. 10.1186/1476-9255-4-5, 1838907, 17367517.
17. Alzola E, Perez-Etxebarria A, Kabre E, Fogarty DJ, Metioui M, Chaib N, Macarulla JM, Matute C, Dehaye JP, Marino A. Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland. Coupling of the calcium-independent PLA2 with kallikrein secretion. J Biol Chem 1998, 273:30208-30217. 10.1074/jbc.273.46.30208, 9804778.
18. Pochet S, Metioui M, Grosfils K, Gomez-Munoz A, Marino A, Dehaye JP. Regulation of phospholipase D by muscarinic receptors in rat submandibular ductal cells. Cell Signal 2003, 15:103-113. 10.1016/S0898-6568(02)00059-1, 12401525.
19. Nakamoto T, Brown DA, Catalan MA, Gonzalez-Begne M, Romanenko VG, Melvin JE. Purinergic P2X7 Receptors Mediate ATP-induced Saliva Secretion by the Mouse Submandibular Gland. J Biol Chem 2009, 284:4815-4822. 2643514, 19097994.
20. Novak I. Purinergic signalling in epithelial ion transport: regulation of secretion and absorption. Acta Physiol (Oxf) 2011, 202:501-522. 10.1111/j.1748-1716.2010.02225.x, 21073662.
21. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 2007, 28:465-472. 10.1016/j.tips.2007.07.002, 17692395.
22. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio F. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 1997, 159:1451-1458.
23. Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol 2000, 165:4615-4623.
24. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232. 10.1038/nature04515, 16407890.
25. Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, Priori R, McInnes IB, Valesini G, Pitzalis C. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther 2004, 6:R447-456. 10.1186/ar1209, 546280, 15380044.
26. Szodoray P, Alex P, Brun JG, Centola M, Jonsson R. Circulating cytokines in primary Sjogren's syndrome determined by a multiplex cytokine array system. Scand J Immunol 2004, 59:592-599. 10.1111/j.0300-9475.2004.01432.x, 15182255.
27. Bulosan M, Pauley KM, Yo K, Chan EK, Katz J, Peck AB, Cha S. Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjogren's syndrome before disease onset. Immunol Cell Biol 2009, 87:81-90. 10.1038/icb.2008.70, 18936772.
28. Gilboa-Geffen A, Wolf Y, Hanin G, Melamed-Book N, Pick M, Bennett ER, Greenberg DS, Lester S, Rischmueller M, Soreq H. Activation of the Alternative NFkappaB Pathway Improves Disease Symptoms in a Model of Sjogren's Syndrome. PLoS One 2011, 6:e28727. 10.1371/journal.pone.0028727, 3235165, 22174879.
29. Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 2008, 181:2898-2906.
30. Fuller SJ, Stokes L, Skarratt KK, Gu BJ, Wiley JS. Genetics of the P2X7 receptor and human disease. Purinergic Signal 2009, 5:257-262. 10.1007/s11302-009-9136-4, 2686826, 19319666.
31. Stokes L, Fuller SJ, Sluyter R, Skarratt KK, Gu BJ, Wiley JS. Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion. Faseb J 2010, 24:2916-2927. 10.1096/fj.09-150862, 20360457.
32. Sluyter R, Dalitz JG, Wiley JS. P2X7 receptor polymorphism impairs extracellular adenosine 5'-triphosphate-induced interleukin-18 release from human monocytes. Genes Immun 2004, 5:588-591. 10.1038/sj.gene.6364127, 15306849.
33. Sluyter R, Shemon AN, Wiley JS. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J Immunol 2004, 172:3399-3405.
34. Scofield AK, Radfar L, Ice JA, Vista E, Anaya JM, Houston G, Lewis D, Stone DU, Chodosh J, Hefner K, Lessard CJ, Moser KL, Scofield RH. Relation of sensory peripheral neuropathy in Sjogren syndrome to anti-Ro/SSA. J Clin Rheumatol 2012, 18:290-293. 10.1097/RHU.0b013e3182675e4f, 3577358, 22955477.
35. Field J, Browning SR, Johnson LJ, Danoy P, Varney MD, Tait BD, Gandhi KS, Charlesworth JC, Heard RN, Stewart GJ, Kilpatrick TJ, Foote SJ, Bahlo M, Butzkueven H, Wiley J, Booth DR, Taylor BV, Brown MA, Rubio JP, Stankovich J. A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis. PLoS One 2010, 5:e13454. 10.1371/journal.pone.0013454, 2964313, 21049023.
36. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909. 10.1038/ng1847, 16862161.
37. Jursik C, Sluyter R, Georgiou JG, Fuller SJ, Wiley JS, Gu BJ. A quantitative method for routine measurement of cell surface P2X7 receptor function in leucocyte subsets by two-colour time-resolved flow cytometry. J Immunol Methods 2007, 325:67-77. 10.1016/j.jim.2007.06.002, 17618646.
38. The Scripps Research Institute Windows Multiple Document Interface for Flow Cytometry (WinMDI), Version 2.8., 2000. The Scripps Research Institute., http://facs.scripps.edu/software.html
39. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989. 10.1086/319501, 1275651, 11254454., http://stephenslab.uchicago.edu/software.html
40. Denlinger LC, Coursin DB, Schell K, Angelini G, Green DN, Guadarrama AG, Halsey J, Prabhu U, Hogan KJ, Bertics PJ. Human P2X7 pore function predicts allele linkage disequilibrium. Clin Chem 2006, 52:995-1004. 10.1373/clinchem.2005.065425, 16613995.
41. Mahoney JA, Rosen A. Apoptosis and autoimmunity. Curr Opin Immunol 2005, 17:583-588. 10.1016/j.coi.2005.09.018, 16214321.
42. Beer RG, Rischmueller M, Coates T, Purcell AW, Keech CL, McCluskey J, Gordon TP. Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome. Clin Immunol Immunopathol 1996, 79:314-318. 10.1006/clin.1996.0084, 8635291.
43. Portales-Cervantes L, Nino-Moreno P, Salgado-Bustamante M, Garcia-Hernandez MH, Baranda-Candido L, Reynaga-Hernandez E, Barajas-Lopez C, Gonzalez-Amaro R, Portales-Perez DP. The His155Tyr (489C>T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cells from patients with rheumatoid arthritis. Cell Immunol 2012, 276:168-175. 10.1016/j.cellimm.2012.05.005, 22703695.
44. Forchap SL, Anandacoomarasamy A, Wicks J, Di Virgilio F, Baricordi OR, Rubbini M, Trotta F, Wiley J, Manolios N. P2X7 gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosus. Tissue Antigens 2008, 72:487-490. 10.1111/j.1399-0039.2008.01136.x, 18937793.
45. Portales-Cervantes L, Nino-Moreno P, Doniz-Padilla L, Baranda-Candido L, Garcia-Hernandez M, Salgado-Bustamante M, Gonzalez-Amaro R, Portales-Perez D. Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. Hum Immunol 2010, 71:818-825. 10.1016/j.humimm.2010.05.008, 20493226.
46. Cook HT, Botto M. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006, 2:330-337.
47. Candore G, Lio D, Colonna Romano G, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev 2002, 1:29-35. 10.1016/S1568-9972(01)00004-0, 12849055.
48. Hwang SM, Koo NY, Choi SY, Chun GS, Kim JS, Park K. P2X7 Receptor-mediated Membrane Blebbing in Salivary Epithelial Cells. Korean J Physiol Pharmacol 2009, 13:175-179. 10.4196/kjpp.2009.13.3.175, 2766740, 19885034.
49. Hwang SM, Li J, Koo NY, Choi SY, Lee SJ, Oh SB, Castro R, Kim JS, Park K. Role of purinergic receptor in alpha fodrin degradation in Par C5 cells. J Dent Res 2009, 88:927-932. 10.1177/0022034509342227, 19783801.
50. Gu BJ, Saunders BM, Petrou S, Wiley JS. P2X(7) is a scavenger receptor for apoptotic cells in the absence of its ligand, extracellular ATP. J Immunol 2011, 187:2365-2375. 10.4049/jimmunol.1101178, 21821797.
51. Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 2009, 2:7:621-668.
52. Sidiropoulos PI, Goulielmos G, Voloudakis GK, Petraki E, Boumpas DT. Inflammasomes and rheumatic diseases: evolving concepts. Ann Rheum Dis 2008, 67:1382-1389. 10.1136/ard.2007.078014, 17921182.
53. Al-Shukaili A, Al-Kaabi J, Hassan B. A comparative study of interleukin-1beta production and p2x7 expression after ATP stimulation by peripheral blood mononuclear cells isolated from rheumatoid arthritis patients and normal healthy controls. Inflammation 2008, 31:84-90. 10.1007/s10753-007-9052-0, 18040764.
54. Cai FZ, Lester S, Lu T, Keen H, Boundy K, Proudman SM, Tonkin A, Rischmueller M. Mild autonomic dysfunction in primary Sjogren's syndrome: a controlled study. Arthritis Res Ther 2008, 10:R31. 10.1186/ar2385, 2453776, 18328102.